Search clinical trials for: Placebo to Duloxetine

Total 61046 results

Université de Montréal
Centre hospitalier de l'Université de Montréal (CHUM)

Completed

Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)

Attention Deficit Disorder With Hyperactivity

Canada
Eli Lilly and Company

Completed

Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain

Osteoarthritis Knee Pain

United States, Russian Federation, Greece, Sweden
Eli Lilly and Company

Completed

Duloxetine Versus Placebo for Osteoarthritis Knee Pain

Osteoarthritis Knee Pain

United States, Puerto Rico, Romania
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

Depressive Disorder, Major

United States, France, Germany, Italy, Russian Federation, Sweden
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052) (C-SURFER)

Hepatitis C Virus
Mayo Clinic

Recruiting

Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough (MACS-2)

Interstitial Lung Disease

United States
Mayo Clinic

Recruiting

Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough (MACS-1)

Refractory Chronic Cough

United States
Boehringer Ingelheim

Completed

Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression

Depressive Disorder, Major
Boehringer Ingelheim

Completed

Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain

Depressive Disorder, Major
Eli Lilly and Company

Completed

Duloxetine Versus Placebo for Fibromyalgia

Fibromyalgia

United States
Eli Lilly and Company

Completed

Efficacy and Safety Stress Urinary Incontinence Study

Urinary Incontinence, Stress

Taiwan
Eli Lilly and Company

Completed

Duloxetine Stress Urinary Incontinence Efficacy and Safety Study

Urinary Incontinence, Stress

Korea, Republic of
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Brii Biosciences Limited

Completed

A Study of BRII-297 in Healthy Adult Subjects

Postpartum Depression

Australia
Mansoura University
National Hepatology & Tropical Medicine Research Institute

Completed

Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy

Pain, Postoperative

Egypt
Weill Medical College of Cornell University

Completed

Impact of Duloxetine on Male Fertility

Depression | Infertility, Male

United States
Stanford University

Completed

Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication

Low Back Pain

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome

Fibromyalgia

United States, Puerto Rico
GlaxoSmithKline

Completed

A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA)

Pain, Inflammatory

United Kingdom, Germany, Poland
Genentech, Inc.

Completed

A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission

Ovarian Cancer
Merck Sharp & Dohme LLC

Completed

A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)

Type 2 Diabetes Mellitus
Galapagos NV
Gilead Sciences

Active, not recruiting

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis (FINCH 4)

Rheumatoid Arthritis

Spain, United States, Japan, Korea, Republic of, Taiwan, Belgium, India, Malaysia, Argentina, Australia, Poland, Czechia, Serbia, Germany, New Zealand, Bulgaria, Canada, Chile, France, Hong Kong, Hungary, Ireland, Israel, Italy, Mexico, R... and more
Taisho Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacology Study of TS-142 in Patients With Obstructive Sleep Apnea Hypopnea.

Patients With Mild Obstructive Sleep Apnea Hypopnea

Japan
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions

Neurogenic Urinary Bladder | Neurogenic Bladder Disorder | Neurogenic Dysfunction of the Urinary Bladder | Neurogenic Bladder, Uninhibited | Neurogenic Bladder, Spastic

Netherlands, Germany, Switzerland
Merck Sharp & Dohme LLC

Completed

A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Genital Warts | Cervical Cancers | Vulvar Cancers | Vaginal Cancers
Albert Einstein College of Medicine
National Institute on Aging (NIA)

Completed

Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women

HIV | Aging | AIDS

United States
Novartis Pharmaceuticals
National Institute on Aging (NIA); Amgen; Banner Alzheimer's Institute

Terminated

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS1)

Alzheimers Disease

United States, Belgium, United Kingdom, Germany, Australia, Canada, Spain, Finland, Switzerland, Netherlands
Charles University, Czech Republic

Active, not recruiting

Non Motoric Reactions in Vojta Reflex Locomotion (VojtaRL)

Locomotion Disorder, Neurologic

Czechia
Taisho Pharmaceutical Co., Ltd.

Completed

Early Phase 2 Clinical Study of TS-142 in Patients With Insomnia Disorder

Insomnia Disorder

Japan
Gilead Sciences
Galapagos NV

Completed

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease (Divergence2)

Fistulizing Crohn's Disease

United States, Italy, Belgium, Austria, Canada, Hungary, United Kingdom, Germany, France
Gilead Sciences
Galapagos NV

Terminated

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy (PENGUIN 2)

Psoriatic Arthritis

Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Hungary, Japan, Poland, Spain, Taiwan
Gilead Sciences
Galapagos NV

Completed

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD) (DIVERGENCE 1)

Small Bowel Crohn's Disease

United States, Belgium, United Kingdom, Germany, Spain, Czechia, Canada, Austria, France, Hungary, Italy, Ukraine
Merck Sharp & Dohme LLC

Completed

Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)

Primary Insomnia
Panacea Biotec Ltd

Completed

To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids

Hemorrhoids

India
Sunnybrook Health Sciences Centre

Not yet recruiting

Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE) (RELIFE)

Knee Osteoarthritis

Canada
Serviço de Anestesiologia de Joinville

Completed

Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery (Duloxetine)

Intervertebral Disc Degeneration
University of Maryland, Baltimore
Eli Lilly and Company

Terminated

Duloxetine for the Treatment of Chronic Pelvic Pain

Pelvis Pain Chronic

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Major Depressive Disorder

France, Italy, Russian Federation, South Africa
Gilead Sciences
Galapagos NV

Terminated

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy (PENGUIN 1)

Psoriatic Arthritis

Korea, Republic of, United States, Taiwan, Australia, Canada, Japan, Poland, Spain, New Zealand, Czechia, Hungary, Bulgaria, Russian Federation
michal roll

Terminated

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Depression
Eli Lilly and Company
Shionogi

Completed

A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain

Back Pain Lower Back Chronic

Japan
Cubist Pharmaceuticals LLC

Completed

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Neuropathic Pain | Peripheral Neuropathy

United States
Eli Lilly and Company

Completed

A Study in Participants With Diabetic Peripheral Neuropathic Pain in China

Diabetic Neuropathy, Painful

China
University of Alexandria

Completed

Duloxetine for Pain in Older Adults With Knee Osteoarthritis (OA)

Pain Reduction | Function Improvement

Egypt
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine for the Treatment of Generalized Anxiety Disorder

Generalized Anxiety Disorder

China
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in Chronic Low Back Pain

Back Pain Without Radiation

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder

Anxiety Disorders

United States, Finland, France, Germany, South Africa, Spain, Sweden
Noema Pharma AG

Completed

A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

Childhood-Onset Fluency Disorder

United States, Australia

Search clinical trials for: Placebo to Duloxetine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations